【摘 要】
：
目的:复发直肠癌的治疗较为棘手,迄今为止还没有统一的治疗方案,大多数复发直肠癌患者治疗前已经使用了含奥沙利铂的辅助化疗方案.本研究探讨采用伊立替康/卡培他滨联合同期放疗治疗复发直肠癌的局部疗效和不良反应.方法:入组病例为本院2009.10-2012.07收治的71例复发直肠癌患者.
【机 构】
：
200032 复旦大学附属肿瘤医院
【出 处】
：
第十七届全国临床肿瘤学大会暨2014年CSCO学术年会
论文部分内容阅读
目的:复发直肠癌的治疗较为棘手,迄今为止还没有统一的治疗方案,大多数复发直肠癌患者治疗前已经使用了含奥沙利铂的辅助化疗方案.本研究探讨采用伊立替康/卡培他滨联合同期放疗治疗复发直肠癌的局部疗效和不良反应.方法:入组病例为本院2009.10-2012.07收治的71例复发直肠癌患者.
其他文献
Objective: No standard treatment options are available for HCC progressing despite SOR treatment.The oral multikinase inhibitor REG showed acceptable tolerability and antitumor activity in patients wi
Objective: As a specific inhibitor of thymidylate synthase (TS), raltitrexed has been shown to prolong survival for patients with advanced gastric cancer in our clinical practice.However, the possible
Objective: This retrospective study aims to explore the efficacy of RetroNectin-activated cytokine-induced killer cell (R-CIK) therapy in advanced hepatocellular carcinoma patients, which has not yet
目的:探索青年乳腺癌患者的病理特点及预后.方法:回顾性收集吉林省肿瘤医院2008年1月-2013年12月收治的乳腺癌患者病例,患者均经手术切除证实为乳腺癌,其中66例为年龄小于30岁,87例为年龄31-35岁,随机抽取同期年龄大于35岁的中老年女性乳腺癌患者病例213例作为参照,分析其病历资料及预后情况.结果:青年乳腺癌患者在肿瘤大小、组织学分级、淋巴结转移状态、组织学分级和分子分型方面与中老年乳
Objective: The association between MUC 1 polymorphism rs4072037 and the risk of gastric cancer has been described in several studies.However, these studies yielded inconsistent results, especially in
Objective: Colon and rectum cancer are one of the most common malignancies worldwide.Here we compare serum thymidine kinase 1 (STK1), a novel prognostic marker for survival, with serum CEA and CA199,
Objective: Postoperative leukopenia is often seen in patients with gastric cancer before adjuvant chemotherapy.This retrospective study was carried out to define the incidence of leukopenia after gast
Objective: Tthe effects of apigenin on intensifying the chemosensitivity of HCC cells and an HCC xenograft model in response to 5-fluorouracil (5-fu) were investigated.Method: Studies were performed t
Objective: To explore the feasibility of high-resolution MRI in predicting tumor response in T3 rectal cancer following neoadjuvant chemoradiation therapy.Method: The clinical data of 108 patients wit
目的:观察降低剂量的氟尿嘧啶联合奥沙利铂、伊立替康组成的改良mFOLFOXIRI方案一线治疗晚期结直肠癌的不良反应和疗效.方法:连续收集2010年1月至2014年1月接受mFOLFOXIRI方案化疗的患者,4个周期后,以NCI-CTCAE3.0版记录相关不良反应,以RECIST 1.1标准进行有效性评价.双脱氧链终止测序法进行KRAS、BRAF基因检测.